EXOZYMES INC (EXOZ:NASDAQ)
$7.11 -0.59 (-7.6623%)
Analysed EXOZYMES INC (EXOZ:NASDAQ) News Sources
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
18-03-2026
yahoo.com
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026
25-03-2026
yahoo.com
MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter
31-03-2026
yahoo.com
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
31-03-2026
yahoo.com
eXoZymes Q4 Earnings Call Highlights
31-03-2026
marketbeat.com
EXoZymes Inc (EXOZ) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
01-04-2026
yahoo.com
MDB Capital Holdings LLC (MDBH) Q4 2025 Earnings Call Highlights: Strategic Innovations and ...
07-04-2026
yahoo.com
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast
10-04-2026
yahoo.com
eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program
07-05-2026
yahoo.com
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
08-06-2026
yahoo.com
What is the current price of EXOZYMES INC (EXOZ:NASDAQ)?
The current price of EXOZYMES INC (EXOZ:NASDAQ) is $7.11.
EXOZYMES INC (EXOZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of EXOZYMES INC (EXOZ:NASDAQ) since the previous trading day is $-0.59.
EXOZYMES INC (EXOZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of EXOZYMES INC (EXOZ:NASDAQ) since the previous trading day is -7.6623%.
What is the most recent average sentiment score for EXOZYMES INC (EXOZ:NASDAQ)?
The most recent average sentiment score for EXOZYMES INC (EXOZ:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for EXOZYMES INC (EXOZ:NASDAQ)?
The most recent sentiment for EXOZYMES INC (EXOZ:NASDAQ) is .
SEC-8K** Filing Available For EXOZYMES INC (EXOZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.